Jilin Province Huinan Changlong Bio-pharmacy Company Limited

HKSE 8049.HK

Jilin Province Huinan Changlong Bio-pharmacy Company Limited Current Liabilities for the year ending December 31, 2023: USD 102.16 M

Jilin Province Huinan Changlong Bio-pharmacy Company Limited Current Liabilities is USD 102.16 M for the year ending December 31, 2023, a -1.35% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Jilin Province Huinan Changlong Bio-pharmacy Company Limited Current Liabilities for the year ending December 31, 2022 was USD 103.55 M, a 15.07% change year over year.
  • Jilin Province Huinan Changlong Bio-pharmacy Company Limited Current Liabilities for the year ending December 31, 2021 was USD 89.99 M, a 41.39% change year over year.
  • Jilin Province Huinan Changlong Bio-pharmacy Company Limited Current Liabilities for the year ending December 31, 2020 was USD 63.64 M, a 14.27% change year over year.
  • Jilin Province Huinan Changlong Bio-pharmacy Company Limited Current Liabilities for the year ending December 31, 2019 was USD 55.70 M, a 2.02% change year over year.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
SV Wall Street
HKSE: 8049.HK

Jilin Province Huinan Changlong Bio-pharmacy Company Limited

CEO Mr. Hong Zhang
IPO Date May 24, 2001
Location Hong Kong
Headquarters Grand Plaza, Office Tower Two
Employees 678
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Non-Alcoholic Beverages Personal Care Plastics
Description

Jilin Province Huinan Changlong Bio-pharmacy Company Limited engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People's Republic of China. It offers tablets, capsules, pills, Chinese medicine pretreatment and extraction products, powders for injections, lyophilized powder for injections, small volume injection solutions, APIs, and granules. The company markets its products under the Changlong and Qing Tong brands. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.

StockViz Staff

February 4, 2025

Any question? Send us an email